Abstract
This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adenocarcinoma, Mucinous / pathology
-
Adenocarcinoma, Mucinous / therapy*
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
Carcinoma, Endometrioid / pathology
-
Carcinoma, Endometrioid / therapy*
-
Carcinoma, Ovarian Epithelial / pathology
-
Carcinoma, Ovarian Epithelial / therapy*
-
Chemotherapy, Adjuvant / trends*
-
Cohort Studies
-
Cytoreduction Surgical Procedures / trends*
-
Female
-
Humans
-
Middle Aged
-
Neoadjuvant Therapy / trends*
-
Neoplasm Staging
-
Neoplasms, Cystic, Mucinous, and Serous / pathology
-
Neoplasms, Cystic, Mucinous, and Serous / therapy
-
Ovarian Neoplasms / pathology
-
Ovarian Neoplasms / therapy*
-
Progression-Free Survival
-
Survival Rate